Wilson Sonsini Goodrich & Rosati advised Vividion Therapeutics, Inc. and the lead investors on the deal. Vividion Therapeutics, Inc., a biotechnology company utilizing novel discovery technologies...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Taylor Wessing advised WuXi AppTec on the deal. WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Cullgen Inc. on the deal. Cullgen Inc., a leading biotechnology company developing small molecule therapeutics based on its proprietary uSMITE™...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ally.io on the deal. Ally.io, a high-growth technology company specializing in goal-setting and business execution software, or objective and key...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Day One Biopharmaceuticals on the deal. Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company focused on accelerating new, promising targeted therapies...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Excision BioTherapeutics on the deal. Excision BioTherapeutics, a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised MegaChips Corporation on the deal. SiTime Corporation, a leader in MEMS timing, announced the pricing of its follow-on public offering...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Hawaiian Airlines, Inc. on the deal. Hawaiian Airlines, Inc. (the “company”), a wholly-owned subsidiary of Hawaiian Holdings, Inc., completed an...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Modern Health on the deal. Modern Health, the mental health and wellness platform supporting over 220 enterprises globally, announced that...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati, P.C. advised Nautilus Biotechnology, while Kirkland & Ellis LLP, working alongside Ogier, advised Arya III on the deal. Latham & Watkins...
You must be a Standard 1 Year member to access this content.
Wiersholm and Elvinger Hoss Prussen assisted Alussa Energy on the deal while Wilson Sonsini Goodrich & Rosati and Arendt have advised FREYR AS on the deal....
You must be a Standard 1 Year member to access this content.
Vinson & Elkins LLP advised TPG Pace Tech Opportunities on the deal while Goodwin Procter LLP advised Nerdy Inc. on the deal. TPG Pace Tech Opportunities...
You must be a Standard 1 Year member to access this content.
